Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation

Cancer Immunology, Immunotherapy

Volumn 57, Issue 6, 2008, Pages 849-857

  Wölfel, Catherine ^a   Lennerz, Volker ^a   Lindemann, Eva ^a   Hess, Georg ^a   Derigs, Hans G ^a   Huber, Christoph ^a   Herr, Wolfgang ^a   Wölfel, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Alloreactivity; Expression cloning; HLA mismatch; HLA B*4405; Minor histocompatibility antigen; TRIM22

Indexed keywords

CYCLOSPORIN A; HISTOCOMPATIBILITY ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; CD8+ T LYMPHOCYTE; FEMALE; GENE SEQUENCE; HEMATOPOIETIC CELL; HUMAN; IN VITRO STUDY; LONG TERM CARE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; ALLELES; CD8-POSITIVE T-LYMPHOCYTES; CLONING, MOLECULAR; DNA, COMPLEMENTARY; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA-B ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MINOR HISTOCOMPATIBILITY ANTIGENS; TRANSPLANTATION, HOMOLOGOUS;

EID: 43349108762     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0421-1     Document Type: Article

References (28)

1. Apperley JF, Jones L, Hale G, Waldmann H, Hows J, Rombos Y et al (1986) Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant 1:53-66
2. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14:9-20
3. Britten CM, Meyer RG, Kreer T, Drexler I, Wolfel T, Herr W (2002) The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. J Immunol Methods 259:95-110
4. Daar AS, Fuggle SV, Fabre JW, Ting A, Morris PJ (1984) The detailed distribution of HLA-A, B, C antigens in normal human organs. Transplantation 38:287-292
5. den Haan JM, Meadows LM, Wang W, Pool J, Blokland E, Bishop TL et al (1998) The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279:1054-1057
6. Ennis PD, Zemmour J, Salter RD, Parham P (1990) Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc Natl Acad Sci USA 87:2833-2837
7. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY (1990) Bone marrow allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323:1818-1822
8. Fontaine P, Roy-Proulx G, Knafo L, Baron C, Roy DC, Perreault C (2001) Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nat Med 7:789-794
9. Goulmy E (2006) Minor histocompatibility antigens: from transplantation problems to therapy of cancer. Hum Immunol 67:433-438
10. Griem P, Wallny HJ, Falk K, Rotzschke O, Arnold B, Schonrich G, Hammerling G, Rammensee HG (1991) Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression. Cell 65:633-640
11. Kawase T, Morishima Y, Matsuo K, Kashiwase K, Inoko H, Saji H et al (2007) High-risk HLA allele mismatch combinations responsible for severe acute graft versus host disease and implication for its molecular mechanism. Blood 110(7):2235-2241
12. Keever CA, Leong N, Cunningham I, Copelan EA, Avalos BR, Klein J et al (1994) HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 14:137-145
13. Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462-2465
14. Lemonnier FA, Rebai N, Le BP, Malissen B, Caillol DH, Kourilsky FM (1982) Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay. J Immunol Methods 54: 9-22
15. Lennerz V, Fatho M, Gentilini C, Frye RA, Lifke A, Ferel D et al (2005) The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc Natl Acad Sci USA 102:16013-16018
16. Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L et al (2003) A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 198:679-691
17. McMichael AJ, Parham P, Rust N, Brodsky FM (1980) A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum Immunol 1:121-129
18. Nisole S, Stoye JP, Saib A (2005) TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 3:799-808
19. Obad S, Brunnstrom H, Vallon-Christersson J, Borg A, Drott K, Gullberg U (2004) Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene 23:4050-4059
20. Obad S, Olofsson T, Mechti N, Gullberg U, Drott K (2007) Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow. Leuk Res 31:995-1001
21. Peggs K, Verfuerth S, Pizzey A, Ainsworth J, Moss P, Mackinnon S (2002) Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood 99:213-223
22. Petersdorf EW, Gooley T, Malkki M, Horowitz M (2007) Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. Tissue Antigens 69(Suppl 1):25-30
23. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al (2001) The tripartite motif family identifies cell compartments. Embo J 20:2140-2151
24. Slifka MK, Whitton JL (2001) Functional avidity maturation of CD8+ T cells without selection of higher affinity TCR. Nat Immunol 2:711-717
25. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L et al (1989) Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720-1728
26. Thammavongsa V, Raghuraman G, Filzen TM, Collins KL, Raghavan M (2006) HLA-B44 polymorphisms at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy. J Immunol 177:3150-3161
27. Tissot C, Mechti N (1995) Molecular cloning of a new interferon-induced factor that represses human immunodeficiency virus type 1 long terminal repeat expression. J Biol Chem 270:14891-14898
28. Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98:49-56